Why have so many R&D consortia been created over the last several years in the pharmaceutical industry? How many are there? As new ones emerge, is there overlap with the goals of existing consortia? What are some of the best practices in managing these collaborations?
The November 2015 edition of the Pistoia Alliance newsletter, Innovation in Action, is available to download as a PDF document.
The slides and recording from today's webinar on Biosample exchanges – the past, the current and the future – how do we make it work? are now available. Results from the polls taken during the webinar can be found below the embedded slides.
All the slides from day 1 of our conference in Philadelphia in October 2015 can be found below, including presentations …
At a very productive meeting last week at the ELIXIR Hub in Hinxton, near Cambridge, John Wise and Richard Holland of the Pistoia Alliance worked with Andrew Smith, Premysl Velek and Rafael Jimenez of ELIXIR to understand the intentions and requirements of both parties, and established that much of what we were doing was very similar, if not identical.
The slides and recording from today's webinar on Opportunities for HPC in pharma R&D are now available.
We thought it would be interesting to summarise the entries to the Pistoia Alliance President's Startup Challenge 2015, so that it might inspire others to enter the contest when it returns in 2016.
The presentation and recording from the "Advancing the State of the Art of Antibody 3D Modelling" webinar held on Tuesday 22nd September 2015 are available.
The presentation and recording from the "Analytics in pharma R&D" webinar held on Tuesday 15th September 2015 are available here.